Eamonn Hobbs took over as board chairman for Irish stent-maker Capella Inc.
Hobbs is CEO of Delcath Systems Inc. (NSDQ:DCTH), a New York-based manufacturer of arterially administered cancer treatments, and was CEO and co-founder of AngioDynamics (NSDQ:ANGO). Hobbs fills the position of former Capella chairman Dr. Wolfgang Oster, a managing partner at PolyTechnos Venture-Partners GmbH.
Capella is developing treatments for coronary bifurcation disease, including its Sideguard sidebranch coronary stent and its delivery system, according to a press release.
Hobbs joins former Boston Scientific chief science officer Art Rosenthal, who was named CEO of Cappella in June of 2009.